Drug policy is a politically sensitive and unwieldy issue. The ‘war on drugs’ is still the predominant global drug policy paradigm. Introducing innovative, evidence-based ap-proaches that take adequate account of the side effects of drug policies is still hampered by ideological prejudices. In the long term, the task at the international level is to establish an alternative discourse regarding development-oriented drug policy, in which the voices of civil society actors should be heard as well. Policy-makers should be advised to design drug policy in a way that further development is oriented towards the needs of the target groups at both the producer and the consumer ends of the value chain. Drug policy in the areas of cultivation should not ‘purely’ be seen as a drug control strategy but as a contribution to the long-term transformation of drug economies into legal economies. The success and progress of national and international drug policy should therefore be measured against social and poverty-related indicators. On the consumption side, health issues and harm reduction measures should be brought to the fore.
- Transitions to a sustainable agri-food system: Making rural youth visible and heard in illicit economies
- Digital high-level advocacy tip sheet
- Media and social media advocacy tip sheet
- The You Matter Project: pathways to care for STBBIs.
- Responsiveness and preparedness in addressing drug-related needs of displaced Ukrainians in EU countries bordering Ukraine
- Call for a great peace: Declaration of Colombia's Commission for the Clarification of Truth, Coexistence and Non-repetition
- The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: Insights from young people with lived and living experience
- Prohibited plants: Environmental justice in drug policy
- Calculating worldwide needs for morphine for pain in advanced cancer and proportions feasibly met by country estimates of requirements and consumption